Towards combination target-directed chemotherapy for chronic myeloid leukemia: Role of farnesyl transferase inhibitors

被引：22

作者：

Daley, GQ

机构：

[1] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA

[2] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

SEMINARS IN HEMATOLOGY | 2003年 / 40卷 / 02期

关键词：

D O I：

10.1053/shem.2003.50035

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：11 / 14

页数：4

共 29 条

[1]

Adjei AA, 2000, CANCER RES, V60, P1871

[2] Farnesyl transferase inhibitors block the farnesylation of CENP-E and CENP-F and alter the association of CENP-E with the microtubules [J].

Ashar, HR ;

James, L ;

Gray, K ;

Carr, D ;

Black, S ;

Armstrong, L ;

Bishop, WR ;

Kirschmeier, P .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (39) :30451-30457

[3] High-performance liquid chromatography/mass spectrometry characterization of Ki4B-Ras in PSN-1 cells treated with the prenyltransferase inhibitor L-778,123 [J].

Buser, CA ;

Dinsmore, CJ ;

Fernandes, C ;

Greenberg, I ;

Hamilton, K ;

Mosser, SD ;

Walsh, ES ;

Williams, TM ;

Koblan, KS .

ANALYTICAL BIOCHEMISTRY, 2001, 290 (01) :126-137

[4]

CORTES JE, 2002, BLOOD, V101, P1692

[5] INDUCTION OF CHRONIC MYELOGENOUS LEUKEMIA IN MICE BY THE P210BCR/ABL GENE OF THE PHILADELPHIA-CHROMOSOME [J].

DALEY, GQ ;

VANETTEN, RA ;

BALTIMORE, D .

SCIENCE, 1990, 247 (4944) :824-830

[6]

DALEY GQ, 1991, ADV CANCER RES, V57, P151

[7]

Daley GQ, 2003, BLOOD, V101, P2070

[8] BLAST CRISIS IN A MURINE MODEL OF CHRONIC MYELOGENOUS LEUKEMIA [J].

DALEY, GQ ;

VANETTEN, RA ;

BALTIMORE, D .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (24) :11335-11338

[9] Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome. [J].

Druker, BJ ;

Sawyers, CL ;

Kantarjian, H ;

Resta, DJ ;

Reese, SF ;

Ford, JM ;

Capdeville, R ;

Talpaz, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1038-1042

[10] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

← 1 2 3 →